CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

105 hedge funds and large institutions have $305M invested in Carisma Therapeutics in 2021 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

36% more call options, than puts

Call options by funds: $6.74M | Put options by funds: $4.96M

0.73% more ownership

Funds ownership: 1.18%1.91% (+0.73%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
105
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.74M
Puts
$4.96M
Net Calls
Net Calls Change

Top Buyers

1 +$62.6M
2 +$35.7M
3 +$7.15M
4
Northern Trust
Northern Trust
Illinois
+$6.41M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$6.04M

Top Sellers

1 -$11.5M
2 -$3.41M
3 -$1.72M
4
Wells Fargo
Wells Fargo
California
-$1.33M
5
VF
Virtu Financial
New York
-$1.08M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$302K
52
$286K
53
$275K
54
$259K
55
$243K
56
$232K
57
$211K
58
$205K
59
$186K
60
$183K
61
$182K
62
$163K
63
$149K
64
$137K
65
$124K
66
$119K
67
$117K
68
$116K
69
$112K
70
$106K
71
$101K
72
$96K
73
$75K
74
$74K
75
$70K